A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.
Psychedelic Support
English
90 hours
The MAPS International MDMA-assisted Therapy Training Program is a collaborative training offered by the Multidisciplinary Association for Psychedelic Studies (MAPS) and the Clinical Psychedelic Lab at Monash University. It is designed for qualified mental healthcare professionals seeking training in the safe and effective delivery of MDMA-assisted psychotherapy for PTSD. The program includes live presentations, video case presentations, discussions, scenario-based learning, self-reflection activities, group activities, online coursework, and creative projects. It covers fundamental processes, therapeutic alliances, and personal growth practices relevant to investigational MDMA-assisted therapy. The course runs over approximately 90 hours and combines asynchronous online material, live online seminars, and a 7-day residential intensive. The source states that the course is not currently being offered.
Qualified and experienced mental healthcare professionals, including Authorised Prescribers and their teams, and therapists involved in ongoing or upcoming clinical trials.
Qualified and experienced mental healthcare professionals; the source does not specify additional entry requirements.
Psychedelic Support is an online education and therapeutic platform offering accredited continuing education, online courses, and a vetted directory of licensed healthcare providers and community groups focused on psychedelic integration, harm reduction, and clinical referrals. It was founded in March 2018 to advance legal psychedelic-assisted therapies and professional training. ([psychedelic.support](https://psychedelic.support/our-story/))
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026
By Phoenix Academy
Online course in clinical psychedelic therapy covering preparation, dosing, safety, integration, and work with co-therapists and clients. Includes videos, interactive content, quizzes, and course documents.